+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact

  • PDF Icon

    Report

  • 175 Pages
  • December 2022
  • Region: Global
  • The Business Research Company
  • ID: 5709773
Major players in the bleeding disorders treatment market are AbbVie Inc, Bayer AG, Novo Nordisk A/S, Pfizer Inc., Biogen, CSL Behring, Grifols S.A., Octapharma AG, BDI Pharma Inc., Ferring Pharmaceuticals, Xenetic Biosciences, Sanofi S.A., Alnylam Pharmaceuticals Inc., and Novartis AG.

The global bleeding disorders treatment market is expected to grow from $12.35 billion in 2021 to $13.65 billion in 2022 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The bleeding disorders treatment market is expected to grow to $18.50 billion in 2026 at a CAGR of 7.9%.

The bleeding disorders treatment market includes revenues earned by entities by recombinant coagulation factor concentrates, plasma-derived coagulation factor concentrates. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Bleeding disorders are a group of diseases caused due to the inability of the blood to clot properly. Symptoms of bleeding disorders include extended bleeding after surgery, injury, menstruation, or trauma. The treatment is used to either stop or reduce the frequency of bleeding episodes.

North America was the largest region in the bleeding disorders treatment market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The main treatment types of bleeding disorders treatment are desmopressin (DDAVP), hormone replacement therapy, contraceptives, anti-fibrinolytic or clot-stabilizing drugs, fibrin sealants, drugs applied to cuts, and pipeline analysis. Desmopressin (DDAVP) treatments are used to diagnose individuals who have mild hemophilia A or von Willebrand disease in stopping bleeding. The types of diseases involved are hemophilia A, hemophilia B, von willebrand disease, liver disease, and others that are served by various end users such as hospitals, clinics, specialty clinics, research institutes, and others.

The increasing number of diagnosed hemophilia patients is expected to propel the growth of the bleeding disorders treatment market going forward. Hemophilia is an inherited bleeding disorder where the blood does not clot properly. The treatment of Hemophilia entails replacement therapy, in which the missing or insufficient blood clotting factors are replaced with human plasma concentrates or recombinant (created from DNA) forms of clotting factors VIII or IX. For instance, in August 2020, according to the World Federation of Hemophilia, a Canada-based international, non-profit organization, in 2020 the total number of people with bleeding disorders was 3,47,026 the number of people with Hemophilia was 2,09,614, and people with hemophilia A was 1,65,379 and people suffering with hemophilia B accounted for 33,076 across the world. Therefore, the increasing number of diagnosed hemophilia patients is driving the growth of the bleeding disorders treatment market.

Technological advancements are the key trend gaining popularity in the bleeding disorder treatment market. Major companies operating in the bleeding disorder treatment sector is focused on developing innovative technologies to sustain their position in the market. For instance, in 2021, the University of Oslo, a Norway-based public research university, developed a new technology called super albumin that can lead to the development of long-acting medications and have significant implications for people with hemophilia. The University's research team has created a novel biomedical technology that can be used to make coagulation factors that have a much longer half-life than those that are currently available. An in-depth analysis of a biological mechanism serves as the starting point. Using this knowledge, they were able to create super albumin, a protein variant that can be combined with protein-based medications to prolong their bloodstream half-life.

In January 2019, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company acquired Shire plc for an undisclosed amount. With the acquisitions, Takeda is expected to have an appealing, expanded geographic footprint and holds a dominant position in both Japan and the United States. With committed staff members worldwide, Takeda can distribute its highly innovative medicines to about 80 countries/regions. Shire plc is a UK-based specialty biopharmaceutical company that provides treatment for hemophilia patients.

The countries covered in the bleeding disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The bleeding disorders treatment market research report is one of a series of new reports that provides Bleeding disorders treatment market statistics, including bleeding disorders treatment industry global market size, regional shares, competitors with bleeding disorders treatment market share, detailed Bleeding disorders treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorders treatment industry. This bleeding disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.



This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Bleeding Disorders Treatment Market

What is the estimated value of the Global Bleeding Disorders Treatment Market?

The Global Bleeding Disorders Treatment Market was estimated to be valued at $13.65 billion in 2022.

What is the growth rate of the Global Bleeding Disorders Treatment Market?

The growth rate of the Global Bleeding Disorders Treatment Market is 7.9%, with an estimated value of $18.5 billion by 2026.

What is the forecasted size of the Global Bleeding Disorders Treatment Market?

The Global Bleeding Disorders Treatment Market is estimated to be worth $18.5 billion by 2026.

Who are the key companies in the Global Bleeding Disorders Treatment Market?

Key companies in the Global Bleeding Disorders Treatment Market include AbbVie Inc., Bayer AG, Novo Nordisk A/S, Pfizer Inc., Biogen, CSL Behring, Grifols S.A., Octapharma AG and Ferring Pharmaceuticals.

Table of Contents

1. Executive Summary2. Bleeding Disorders Treatment Market Characteristics3. Bleeding Disorders Treatment Market Trends And Strategies
4. Bleeding Disorders Treatment Market - Macro Economic Scenario
4.1. COVID-19 Impact On Bleeding Disorders Treatment Market
4.2. Ukraine-Russia War Impact On Bleeding Disorders Treatment Market
4.3. Impact Of High Inflation On Bleeding Disorders Treatment Market
5. Bleeding Disorders Treatment Market Size And Growth
5.1. Global Bleeding Disorders Treatment Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Bleeding Disorders Treatment Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Bleeding Disorders Treatment Market Segmentation
6.1. Global Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Desmopressin (DDAVP)
  • Hormone Replacement Therapy
  • Contraceptives
  • Anti-Fibrinolytic or Clot-Stabilizing Drugs
  • Fibrin Sealants
  • Drugs Applied To Cuts
  • Pipeline Analysis
6.2. Global Bleeding Disorders Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hemophilia A
  • Hemophilia B
  • Von willebrand disease
  • Liver disease
  • Other Disease Types
6.3. Global Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Clinics
  • Speciality Clinics
  • Research Institutes
  • Other End Users
7. Bleeding Disorders Treatment Market Regional And Country Analysis
7.1. Global Bleeding Disorders Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Bleeding Disorders Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Bleeding Disorders Treatment Market
8.1. Asia-Pacific Bleeding Disorders Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Bleeding Disorders Treatment Market
9.1. China Bleeding Disorders Treatment Market Overview
9.2. China Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Bleeding Disorders Treatment Market
10.1. India Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Bleeding Disorders Treatment Market
11.1. Japan Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Bleeding Disorders Treatment Market
12.1. Australia Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Bleeding Disorders Treatment Market
13.1. Indonesia Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Bleeding Disorders Treatment Market
14.1. South Korea Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Bleeding Disorders Treatment Market
15.1. Western Europe Bleeding Disorders Treatment Market Overview
15.2. Western Europe Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Bleeding Disorders Treatment Market
16.1. UK Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Bleeding Disorders Treatment Market
17.1. Germany Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Bleeding Disorders Treatment Market
18.1. France Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.2. France Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Bleeding Disorders Treatment Market
19.1. Eastern Europe Bleeding Disorders Treatment Market Overview
19.2. Eastern Europe Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Bleeding Disorders Treatment Market
20.1. Russia Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Bleeding Disorders Treatment Market
21.1. North America Bleeding Disorders Treatment Market Overview
21.2. North America Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Bleeding Disorders Treatment Market
22.1. USA Bleeding Disorders Treatment Market Overview
22.2. USA Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Bleeding Disorders Treatment Market
23.1. South America Bleeding Disorders Treatment Market Overview
23.2. South America Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Bleeding Disorders Treatment Market
24.1. Brazil Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Bleeding Disorders Treatment Market
25.1. Middle East Bleeding Disorders Treatment Market Overview
25.2. Middle East Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Bleeding Disorders Treatment Market
26.1. Africa Bleeding Disorders Treatment Market Overview
26.2. Africa Bleeding Disorders Treatment Market, Segmentation By Treatment, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Bleeding Disorders Treatment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Bleeding Disorders Treatment Market Competitive Landscape And Company Profiles
27.1. Bleeding Disorders Treatment Market Competitive Landscape
27.2. Bleeding Disorders Treatment Market Company Profiles
27.2.1. AbbVie Inc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bayer AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Novo Nordisk A/S
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Pfizer Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Biogen
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Bleeding Disorders Treatment Market29. Bleeding Disorders Treatment Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

Executive Summary

Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact provides the strategists, marketers and senior management with the critical information they need to assess the global bleeding disorders treatment market.

This report focuses on bleeding disorders treatment market which is experiencing strong growth. The report gives a guide to the bleeding disorders treatment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Assessment of Russia - War Impact on agriculture, energy and mineral commodities supply and their direct and indirect impact on the market analyzed in the report.
  • Impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the bleeding disorders treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Bleeding Disorders Treatment market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider bleeding disorders treatment market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Our forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of covid 19 on supply chains and consumption patterns.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The bleeding disorders treatment market section of the report gives context. It compares the bleeding disorders treatment market with other segments of the bleeding disorders treatment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, bleeding disorders treatment indicators comparison.

Scope

Markets Covered:

1) By Treatment: Desmopressin (DDAVP); Hormone Replacement Therapy; Contraceptives; Anti-Fibrinolytic or Clot-Stabilizing Drugs; Fibrin Sealants; Drugs Applied To Cuts; Pipeline Analysis
2) By Disease Type: Hemophilia A; Hemophilia B; Von willebrand disease; Liver disease; Other Disease Types
3) By End User: Hospitals; Clinics; Speciality Clinics; Research Institutes; Other End Users

Companies Mentioned: AbbVie Inc.; Bayer AG; Novo Nordisk A/S; Pfizer Inc.; Biogen

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Bayer AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Biogen
  • CSL Behring
  • Grifols S.A.
  • Octapharma AG
  • BDI Pharma Inc.
  • Ferring Pharmaceuticals
  • Xenetic Biosciences
  • Sanofi S.A.
  • Alnylam Pharmaceuticals Inc.
  • Novartis AG

Methodology

Loading
LOADING...